Endothelins and Kidney Diseases

Nephron

Volumn 72, Issue 3, 1996, Pages 375-382

  Brown, Maritza ^a   Yih Chon, Shyan ^a   Porush, Jerome G ^a  

^a BROOKDALE UNIVERSITY HOSPITAL AND MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRAST MEDIUM; CYCLIC AMP; CYCLOSPORIN; ENDOTHELIN; ENDOTHELIN RECEPTOR; MESSENGER RNA;

ACUTE KIDNEY FAILURE; ADRENERGIC SYSTEM; DISEASE COURSE; EDITORIAL; GLOMERULUS FILTRATION RATE; HEPATORENAL SYNDROME; HUMAN; HYPERTENSION; KIDNEY BLOOD VESSEL; KIDNEY DISEASE; NEPHROTOXICITY; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; VASCULAR ENDOTHELIUM;

ANIMALS; ENDOTHELINS; HUMANS; KIDNEY DISEASES;

EID: 0030024702     PISSN: 16608151     EISSN: 22353186     Source Type: Journal    
DOI: 10.1159/000188899     Document Type: Article

References (94)

1. Furchgott RF, Zawadzki JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 1980;288:373-376.
2. Hickey KA. Rubanvi G. Paul RJ. Highsmith RF: Characterization of a coronary vasoconstrictor produced by cultured endothelial cells. Am J Physiol 1985;248:C550-C556.
3. Palmer RMJ. Fcrrigc AG. Moncada S: Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 1987;327:524-526.
4. Ignarro U: Biological actions and properties of endothelium-derived nitric oxide formed and released from artery and vein. Circ Res 1989: 65:1-21.
5. Yanagisawa M. Kunhara H. Kimura S. Tomobe Y, Kobayashi M. Mitsui Y. Yazaki Y. Goto K. Masaki T: A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 1988:332:411-415.
6. Inouc A. Yanagisawa M. Kimura S, Kasuya Y. Miyauchi T. Goto K. Masaki T: The human endothelin family: Three structurally and pharmacologically distinct isopeptides predicted by three separate genes. Proc Natl Acad Sci USA 1989:86:2863-2867.
7. Arinami T. Ishikawa M. Inoue A. Yanagisawa M, Masaki T, Yoshida MC. Hamaguchi H: Chromosomal assignments of the human endothelin family genes: The cndothclin-l gene to 6p23-p24. the cndothelin-2 gene to I p34. and the endothclin-3 gene to 20ql 3.2-113.3. Am J Hum Genet 1991:48:990-996.
8. Sokolovsky M: Endothelins and sarafotoxins: Physiological regulation, receptor subtypes and transmembrane signaling. Pharmacol Ther 1992:54:129-149.
9. Masaki T. Kimura S. Yanagisawa M, Goto K: Molecular and cellular mechanism of endothelin regulation: Implications for vascular function. Circulation 1991;84:1457-1468.
10. McMahon EG. Palomo MA. Moore WM. McDonald JF. Stern MK: Phosphoramidon blocks the pressor activity of porcine big endothelin-1-(1-39) in vivo and conversion of big endothelin-l-(l-39) to endothelin-1-(1-21) in vitro. Proc Natl Acad Sci USA 1991:88:703-707.
11. Simonson MS: Endothelins: Multifunctional renal peptides. Physiol Rev 1993:73:375-411.
12. Kohan DE: Endothelins in the kidney: Physiology and pathophysiology. Am J Kidney Dis 1993;22:493-510.
13. Marsen TA. Schramek H, Dunn MJ: Renal actions of endothelin: Linking cellular signaling pathways to kidney disease. Kidney Int 1994: 45:336-344.
14. Rubanvi GM, Parker Botclho LH: Endothelins. FASEBJ 1991;5:2713-2720.
15. Arai H. Hon S. Aramori L. Ohkubo H. Nakani-shi S: Cloning and expression of a cDNA encoding an endothelin receptor. Nature 1990: 348:730-732.
16. Hosoda K. Nakao K, Tamura N, Arai H, Oga-wa Y. Suga S. Nakanishi S. lmura II: Organization, structure, chromosomal assignment and expression of the gene encoding the human cndothclin-A receptor. J Biol Chem 1992:267: 18797-18804.
17. Sakamoto A, Yanagisawa M, Sakurai T, Taku-wa Y, Yanagisawa H. Masaki T: Cloning and functional expression of human cDNA for the ETi! endothelin receptor. Biochcm Biophys ResCommun 1991:178:656-663.
18. Chou S-Y, Dahhan A, Porush JG: Renal actions of endothelin: Interaction with prostacyclin. Am J Physiol 1990:259:F645-F652.
19. Miura K. Yukimura T. Yamashita Y, Shim-men T. Okumura M. Yamanaka S. Imanishi M. Yamamoto K: Renal and femoral vascular responses to cndothclin-l in dogs: Role of prostaglandins. J Pharmacol Exp Ther 1991:256: 11-17.
20. Banks RO: Effects of endothelin on renal function in dogs and rats. Am J Phvsiol 1990:259: F775-F780.
21. Chou S-Y. Ramamurthy G. Porush JG: Endothelin stimulates renal production of endothelium-derived relaxing factor. J Am Soc Nephrol 1992:3:379A.
22. Kon V. Yoshioka T. Fogo A. Ichikawa I: Glomerular actions of endothelin in vivo. J Clin Invest 1989:83:1762-1767.
23. King A, Brenner BM. Anderson S: Endothelin: A potent renal anc systemic vasoconstrictor peptide. Am J Physiol 1989:256:F1051-F1058.
24. Loutzenhiser R. Epstein M, Hayashi K. Horton C: Direct visualization of effects of endothelin on the renal microvasculature. Am J Physiol 1990;258:F61-F68.
25. Edwards RM, Trizna W. Ohlstcin EH: Renal microvascular effects of endothelin. Am J Physiol 1990:259: p F217-F221.
26. Takenaka T. Forster H. Epstein M: Protein kinase C and calcium channel activation as determinants of renal vasoconstriction by angiotensin II and endothelin. Circ Res 1993:73: 743-750.
27. Badr K, Murray JJ. Breyer MD. Takahashi K. Inagami T. Harris RC: Mesangial cell, glomerular and renal vascular responses to endothelin in the rat kidney: Elucidation of signal transduction pathways. J Clin Invest 1989:83:336-342.
28. Sorensen SS. Madsen JK. Pedersen EB: Systemic and renal effect of intravenous infusion of cndothclin-l in healthy human volunteers. Am J Physiol 1994;266:F411-F418.
29. Tomita K. Nonoguehi H, Marumo F: Effects of endothelin on peptide-dependent cyclic adenosine monophosphate accumulation along the nephron segments of the rat. J Clin Invest 1990:85:2014-2018.
30. Kohan D. Padilla E, Hughes AK: Endothelin B receptor mediates ET-1 effects on cAMP and PGE; accumulation in rat IMCD. Am J Physiol 1993;265:F670-F676.
31. Zcidel ML. Brady HR. Konc BC. Gullans SR. Brenner BM: Endothelin. a peptide inhibitor of NaMC-ATPase in intact renal tubular epithelial cells. Am J Physiol 1989;257:C1101-C1107.
32. Goetz KL. Wang BC. Madwcd JB. Zhu JL. Lcadlcy RJ Jr: Cardiovascular, renal and endocrine responses to intravenous endothelin in conscious dogs. Am J Physiol 1988:255: R1064-R1068.
33. Miller WL, Redfield MM. Burnett JC Jr: integrated cardiac, renal, and endocrine actions of endothelin. J Clin Invest 1989;83:317-320.
34. Uzundcr K. Banks RO: Endothclin-induced natriuresis and diuresis are pressure-dependent events in the rat. Am J Physiol 1993;265:R90-R96.
35. Cao L. Banks RO: Cardiovascular and renal actions of endothelin: Effects of calcium-channel blockers. Am J Physiol 1990;258:F254-F258.
36. lhara M, Fukuroda T. Sacki T. Nishikibc M. Kojiri K, Suda H. Yano M: An endothelin receptor (ETa) antagonist isolated from Slrep-lomyces niisakiensis. Biochcm Biophys Res Commun 1991.178:132-137.
37. Cirino M. Motz C. Maw J. Ford-Hutchinson AW. Yano M: BQ-153, a novel endothelin (ETa) antagonist, attenuates the renal vascular effects of endothelin-1. J Pharm Pharmacol 1991:44:782-785.
38. Cristol J-P. Warner TD, Thiemcrmann C. Vane JR: Mediation via different receptors of the vasoconstrictor effects of endothelins and sarafotoxins in the systemic circulation and renal vasculature of the anesthetized rat. Br J Pharmacol 1993:108:776-779.
39. Warner TD. Allcock GH. C'ordcr R. Vane JR: Use of the endothelin antagonists BQ-123 and PD 142893 to reveal three endothelin receptors mediating smooth muscle contraction and the release of EDRF. Br J Pharmacol 1993:110: 777-782.
40. Clavcll AL. Stingo AJ, Margulies KB. Brandt RR. Burnett JC Jr: Role of endothelin receptor subtypes in the in vivo regulation of renal function. AmJ Physiol 1995:268:F455-F460.
41. B receptors increases glomerular cGMP via an L-arginine-dependent pathway Am J Physiol 1992:263:F1020-FI 025.
42. Brook DP. DePalma PD. Pullen M, Nambi P: Characterization of canine renal endothelin receptor subtypes and their function. J Pharmacol Exp Ther 1994:268:1091-1097.
43. A receptor antagonist in the rat. J Clin Invest 1994:93: 900-906.
44. Chan L. Chittinandana A. Shapiro JI, Shanley PF. Schrier RW: Effect of an endothelin-rcccp-tor antagonist on ischemic acute renal failure. Am J Physiol 1994;266:F135-F138.
45. Wilkes B. Pearl AR. Mento PF. Maita ME. Cacica CM. Girardi EP: Glomerular endothelin receptors during initiation and maintenance of ischemic acute renal failure in rats. Am J Physiol 1991;260:F110-F118.
46. Tomita K, Ujiie K. Nakashishi T. Tomura S, Matsuda O. Ando K, Schichibi M, Hirata Y, Marumo F: Plasma endothclin levels in patients with acute renal failure. N Engl J Med 1989:321:1127.
47. Watschinger B. Vychytil A. Schuller M. Hartlcr E. Traindl O: The pathophysiologic role of endothelin in acute vascular rejection after renal transplantation. Transplantation 1991:52: 743-746.
48. Yamada K. Gunji Y. Hishikawa E, Kashiwaba-ra II. Sakamoto K. Arita S. Yokoyama T: Possible involvement of endothelin in posttransplant acute tubular necrosis. 1. Studies in renal transplant patients. Transplantation 1994:57: 1137-1139.
49. Epstein M: The hepatorenal syndrome: Newer perspectives. N Engl J Med 1992:327:1810-1811.
50. Moore K. Wendon J. Frazer M. Karani J. Williams R. Badr K: Plasma endothelin intmuno-rcactivitv in liver disease and the hepatorenal syndrome. N Engl J Med 1992:327:1774-1778.
51. Uchihar M. Izumi N. Sato C. Marumo F: Clinical significance of elevated plasma endothelin concentration in patients with cirrhosis. Hepatology 1992:16:95-99.
52. Moncada W, Palmer RMJ, Higgs EA: Nitric oxide: Physiology, pathophysiology and pharmacology. Pharmacol Rev 1991:43:109-141.
53. Guarncr C. Soriano G, Tomas A. Bulbcna O. Novella MT, Balanozo J. Vilardell F. Mourelle M. Moncada S: Increased scrum nitrite and nitrate levels in patients with cirrhosis: Relationship to endotoxemia. Hepatology 1993:18: 1139-1143.
54. Myers BD: Cyclosporine nephrotoxicity. Kidney Int 1986;30:964-974.
55. Iau DCW. Wong K-L. Hwang WS: Cyclosporine toxicity on cultured rat microvascular endothelial cells. Kidney Int 1989:35:604-613.
56. Grieff M. Loertscher R, Shohaib S. Stewart DJ: Cyclosporine-induced elevation in circulating cndothelin-l in patients with solid-organ transplants. Transplantation 1993:56:880-884.
57. Bunchman T. Brookshire CA: Cyclosporine-induced synthesis of endothelin by cultured human endothelial cells. J Clin Invest 1991;88: 310-314.
58. Iwasaki S, Homma T. Kon V: Site-specific regulation in the kidney of endothelin and its receptor subtypes by cyclosporine. Kidney Int 1994;45:592-597.
59. B receptor by producing nitric oxide in isolated rat glomerulus, and in cultured rat mesangial cells. J Clin Invest 1994:93: 556-563.
60. Ishikawa K. Ihara M. Noghuchi K. Mase T. Mino N. Saeki T, Fukuroda T. Fukame T. Oza-ki S. Nagase T, Nishikibe M. Yano M: Biochemical and pharmacological profile of a potent and selective endothclin B-receptor antagonist. BQ-788. Proc Natl Acad Sci USA 1994: 91:4892-4896.
61. Nucci G. Thomas R. D'Orleans-Juste P. An-tunes E. Walder C. Warner TD. Vane JR: Pressor effects of circulating endothclin arc limited by its removal in the pulmonary circulation and by the release of prostacyclin and endothelium-derived relaxing factor. Proc Natl Acad Sci USA 1988:85:9797-9800.
62. Vijayaraghavan J. Scicli AG. C'arretero OA. Slaughter C. Moomaw C. Hersh LB: The hydrolysis of endothelins by neutral endopepti-dase24.11 (enkephalinasc). J Biol Client 1990; 265:14150-14155.
63. Abassi ZA. Klein H. Golomb E, Keiser HR: Urinary endothclin: A possible biological marker of renal damage. Am.1 Hypcrtens 1993: 6:1046-1054.
64. Abassi ZA, Tate JE. Golomb E. Keiser HR: Role of neutral endopeptidase in the metabolism of endothclin. Hypertension 1992:20:89-95.
65. Moore K, Wendon J. Frazer M. Karani J. Williams R, Badr K: Plasma endothclin immuno-reactivity in liver disease and the hepatorenal syndrome. N Engl J Med 1992:327:1774-1778.
66. Olita K. Hirata Y. Shichiri M. Kanno K. Emori T. Tomita K, Marumo F: Urinary excretion of cndothelin-l in normal subjects and patients with renal disease. Kidney Int 1991:39:307-311.
67. Ando K. Hirata Y. Takci Y. Kawakami M. Marumo F: Endothclin-1-likc immunoreactivi-tv in human urine. Nephron 1991:57:36-39.
68. Firth JD. Ratcliffc P.I. Raine AEG, Lcdingham JGG: Endothelin: An important factor in acute renal failure? Lancet 1988:ii:1179-1182.
69. Shibouta Y. Suzuki N. Shino A. Matsumoto H. Terashita Z-I. Kondo K. Nishikawa K: Pathophysiological role of endothclin in acute renal failure. Life Sci 1990:46:1611-1618.
70. Nambi P. Pullen M. Jugus M. Gcllai M: Rat kidney endothelin receptors in ischemia-induced acute renal failure. J Pharmacol Exp Ther 1993;264:345-348.
71. Mino N. Kobayashi M. Nakayjima A. Amano II. Shimamot K. Ishikawa K, Watanabc K. Nishikibe M. Yano M. Ikemoto F: Protective effect of a selective endothelin receptor antagonist. BQ-123, in ischemic acute renal failure in rats. Eur J Pharmacol 1992:221:77-83.
72. Kon V, Sugiura M. Inagami T. Harvic BR. Ichikawa I. Hoover R: Role of endothelin in cyclosporine-induced glomerular dysfunction. Kidney Int 1990:37:1487-1491.
73. Perico N, Dadan J. Remuzzi G: Endothclin mediates the renal vasoconstriction induced by cyclosporine in the rat. J Am Soc Nephrol 1990:1:76-83.
74. Kivlighn S. Gabel RA. Siegl PKS: Effects of BQ-123 on renal function and acute cyclosporine-induced renal dysfunction. Kidney Int 1994:45:131-136.
75. Fisch J, Gulmi FA. Chou S-Y. Mooppan UMM. Kestcr RR. Kim H: The renal hemodynamic response to endothelin in chronic cyclosporine-treated dogs. J Urol 1993; 149:878-883.
76. Roullet J-B. Xuc H. McCarron DA. Holcomb S. Bennett WM: Vascular mechanisms of cyclosporin-induced hypertension in the rat. J Clin Invest 1994;93:2244-2250.
77. Gaston RS. Schlcssinger SD, Wanders PW. Barker CV. Curtis JJ. Wamock D: Cyclosporine inhibits the renal response to L-arginine in human kidney transplant recipients. J Am Soc Nephrol 1995:5:1426-1433.
78. Brezis M. Rosen S: Hypoxia of the renal medulla: Its implications for disease. N Engl J Med 1995:332:647-655.
79. Hevman SN. Clark BA. Kaiser N. Spokes K, Rosen S. Brezis M. Epstein FH: Radiocontrast agents induce endothelin release in vivo and in vitro. J Am Soc Nephrol 1992;3:58-65.
80. Margulies KB. Hildebrand FL. Heublcin DM. Burnett JC Jr: Radiocontrast increases plasma and urinary endothelin. J Am Soc Nephrol 1991;2:1041-1045.
81. Cantley LG, Spokes K. Clark B. McMahon EG. Carter J, Epstein FH: Role of endothclin and prostaglandins in radiocontrast-induced renal artery constriction. Kidney Int 1993:44:1217-1223.
82. Shaft T. Chou S-Y. Porush JG. Shapiro WB: Infusion intravenous pyelography and renal function: Effects in patients with chronic renal insufficiency. Arch Intent Med 1978:138: 1218-1221
83. Simonson MS, Wann S. Mette P. Dubyak GR. Kesier M. Nakazato Y. Sedor JR, Dunn MJ: Endothclin stimulates phospholipase C. Na/H exchange, c-fos expression, and ontogenesis in rat mesangial cells. J Clin Invest 1989,83:708-712.
84. Bcnigni A. Perico N. Gaspari F. Zoja C. Belliz-zi L. Gabanelli M. Remuzzi G: Increased renal endothclin production in rats w ith reduced renal mass. Ant J Physiol 1991;260:F331-F339.
85. Orisio S. Bcnigni A. Bruzzi I. Corna D. Perico N. Zoja C. Benatti L, Remuzzi G: Renal endothelin gene expression is increased in remnant kidney and correlates with disease progression. Kidney Int 1993:43:354-358.
86. Benigni A. Zoja C, Corna D, Orisio S, Longa-rctti L. Beriani T, Remuzzi G: A specific cndo-thclin subtype A receptor antagonist protects against injury in renal disease progression. Kidney Int 1993;44:440-444.
87. Kohno M. Yasunari K. Murakawa KI, Yokokava K. Horio T. Fukui T. Takcda T: Plasma immunoreactive endothelin in essential hypertension. Am J Med 1990;88:614-618.
88. Shichiri M, Hirata Y. Ando K. Emori T. Ohla K. Kimoto S. Ogura M. Inoue A, Marumo F: Plasma endothelin levels in hypertension and chronic renal failure. Hypertension 1990:15: 493-496.
89. Schiffrin ET. Thibault G: Plasma endothelin in human essential hypertension. Am J Hypcrtcns 1991:4:303-308.
90. Li JS. Larivièrc R. SchilTrin EL: Effect of a non-selective endothelin antagonist on vascular remodeling in deoxycorticosterone acetate-salt hypertensive rats: Evidence for a role of endothelin in vascular hypertrophy. Hypertension 1994:24:183-188.
91. Hirata Y. Matsuoka H. Kimura K. Fukui K, Hayakawa S, Suzuki E, Sugimoto T, Sugimoto T. Yanagisawa M, Masaki T: Renal vasoconstriction by the endothelial cell-derived peptide endothelin in spontaneously hypertensive rats. Circ Res 1989;65:1370-1379.
92. Dohi Y, Lüscher TF: Endothelin in hypertensive resistance arteries: Intraluminal and extraluminal dysfunction. Hypertension 1991:18: 543-549.
93. SchitTrin EL. Deng LY. Larochelle P: Blunted effects of endothelin upon small subcutaneous resistance arteries of mild essential hypertensive patients. J Hypertens 1992;10:437-444.
94. Haynes WG. Hand MF. Hohnstonc HA, Pad-field PL. Webb DJ: Direct and sympathetically mediated venoconstriction in essential hypertension: Enhanced responses to endothelin-1. J Clin Invest 1994:94:1359-1364.